Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 117,859
  • Shares Outstanding, K 42,703
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,641 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.46
Trade CRDL.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.84
  • Most Recent Earnings -0.26 on 03/31/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.57 +5.84%
on 07/19/21
3.31 -17.82%
on 06/28/21
-0.33 (-10.82%)
since 06/23/21
3-Month
2.57 +5.84%
on 07/19/21
4.42 -38.46%
on 05/03/21
-1.28 (-32.00%)
since 04/23/21
52-Week
1.98 +37.37%
on 08/12/20
5.32 -48.87%
on 02/17/21
+0.32 (+13.33%)
since 07/23/20

Most Recent Stories

More News
Cardiol Therapeutics' Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment...

CRTPF : 2.1750 (-0.68%)
CRDL.TO : 2.72 (-1.45%)
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.1750 (-0.68%)
CRDL.TO : 2.72 (-1.45%)
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT

Oakville, Ontario--(Newsfile Corp. - June 28, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.1750 (-0.68%)
CRDL.TO : 2.72 (-1.45%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

/PRNewswire/ -- The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get...

OILFF : 0.1788 (+2.11%)
OILS.CN : 0.225 (+2.27%)
MNMD : 3.07 (-2.23%)
LKYSF : 0.7600 (-2.56%)
NUMI.VN : 0.950 (-3.06%)
FTRPF : 6.0050 (+1.61%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.1750 (-0.68%)
CRDL.TO : 2.72 (-1.45%)
Cardiol Therapeutics Closes $22 Million Bought Deal Offering

Oakville, Ontario--(Newsfile Corp. - May 12, 2021) - () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.72 (-1.45%)
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND

CRDL.TO : 2.72 (-1.45%)
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES.

CRDL.TO : 2.72 (-1.45%)
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

Oakville, Ontario--(Newsfile Corp. - April 28, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.72 (-1.45%)
CRTPF : 2.1750 (-0.68%)
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - April 12, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.72 (-1.45%)
CRTPF : 2.1750 (-0.68%)
Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A

Oakville, Ontario--(Newsfile Corp. - April 1, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.72 (-1.45%)
CRTPF : 2.1750 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 2.88
2nd Resistance Point 2.83
1st Resistance Point 2.78
Last Price 2.72
1st Support Level 2.68
2nd Support Level 2.63
3rd Support Level 2.58

See More

52-Week High 5.32
Fibonacci 61.8% 4.04
Fibonacci 50% 3.65
Fibonacci 38.2% 3.26
Last Price 2.72
52-Week Low 1.98

See More

Business Summary

Cardiol Therapeutics Inc is a clinical-stage biotechnology company developing therapies for inflammatory heart disease. The company has received approval to commence a Phase II/III clinical trial investigating its product, CardiolRx, in COVID-19 patients with history of cardiovascular disease. CardiolRx...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar